Pathogenic roles of microvesicles in diabetic retinopathy

Wei Zhang1, Song Chen1, Ming-Lin Liu2,3,4

  • 1Tianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Institute, Clinical College of Ophthalmology Tianjin Medical University, Tianjin 300020, China.

Insights

Microvesicles (MVs) are implicated in diabetic retinopathy (DR) pathogenesis, contributing to inflammation and vascular injury. Further research into MVs may reveal new therapeutic targets for preventing diabetes-related blindness.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Cell Biology

Background:

  • Diabetic retinopathy (DR) is a leading cause of adult blindness.
  • DR involves complex molecular pathways, including intercellular communication via microvesicles (MVs).
  • MVs are implicated in tumors and cardiometabolic diseases, but their role in DR is under-investigated.

Purpose of the Study:

  • To review the role of microvesicles in diabetic retinopathy.
  • To discuss mechanisms of MV-induced microvascular injury, endothelial dysfunction, coagulation, and inflammation in DR.
  • To explore potential therapeutic applications of MVs in DR.

Main Methods:

  • Literature review of studies on microvesicles and diabetic retinopathy.
  • Analysis of molecular pathways involved in MV-mediated intercellular communication.
  • Discussion of current understanding and future directions in MV research for DR.

Main Results:

  • Microvesicles derived from endothelial and circulating cells contribute to DR-induced microvascular injury.
  • MVs can promote endothelial dysfunction, coagulation, and inflammation, exacerbating DR pathology.
  • Preconditioned and stem cell-derived MVs show potential protective effects.

Conclusions:

  • Microvesicles play a significant role in the pathophysiology of diabetic retinopathy.
  • Understanding MV involvement offers insights into DR mechanisms.
  • MVs represent a promising area for developing novel therapeutic strategies for DR.